BioLineRx’s Aphexda approved to aid stem cell transplants for multiple myeloma patients

Autologous stem cell transplantation (ASCT) is part of the standard of care for patients with multiple myeloma. It’s a process in which a patient’s own stem cells are removed and reintroduced, often after treatment with chemotherapy. But some patients don’t make good candidates.

Less than half of patients have trouble…
Click here to view original post